Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bitolterol
2. Bitolterol Methanesulfonate
3. S-1540
4. Tornalate
5. Win 32784
1. 30392-41-7
2. Tornalate
3. Bitolterol Mesilate
4. Bitolterol Methanesulfonate
5. Bitolterol Mesilat
6. Bitolterol (mesylate)
7. Bitolterol Mesylate [usan]
8. (tert-butyl)[beta-hydroxy-3,4-bis(p-toluoyloxy)phenethyl]ammonium Methanesulphonate
9. Win 32784
10. Win-32784
11. Win 32,784
12. 4-(2-(tert-butylamino)-1-hydroxyethyl)-o-phenylene Di-p-toluate Methanesulfonate (salt)
13. 4e53t3611u
14. Effectin
15. Bitolterol Mesilate (jan)
16. Bitolterol Mesylate (usan)
17. [4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(4-methylbenzoyl)oxyphenyl] 4-methylbenzoate;methanesulfonic Acid
18. Benzoic Acid, 4-methyl-, 4-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-1,2-phenylene Ester Methanesulfonate (salt)
19. Bitolterol Mesilate [jan]
20. Biterol; Bitoterol Methanesulfonate; Effectin; Tornalate; Win 32784
21. Chebi:3134
22. (tert-butyl)(beta-hydroxy-3,4-bis(p-toluoyloxy)phenethyl)ammonium Methanesulphonate
23. Einecs 250-177-5
24. Asmalene
25. Produrol
26. Unii-4e53t3611u
27. Tornalate (tn)
28. 4-(2-(t-butylamino)-1-hydroxyethyl)-o-phenylene Di-p-toluate Mesilate
29. S-1540
30. Schembl4371
31. Alpha((tert-butylamino)methyl)-3,4-dihydroxybenzyl Alcohol 3,4-di-p-toluate Methanesulfonate (salt)
32. Chembl1200405
33. Dtxsid80952735
34. Bitolterol Mesylate [vandf]
35. Bitolterol Mesilate [mart.]
36. Bitolterol Mesilate [who-dd]
37. Bitolterol Methanesulfonate [mi]
38. Bitolterol Mesylate [orange Book]
39. P-toluic Acid, 4-(2-(tert-butylamino)-1-hydroxyethyl)-o-phenylene Ester, Methanesulfonate(salt)
40. D00684
41. Q27105949
42. .alpha.((tert-butylamino)methyl)-3,4-dihydroxybenzyl Alcohol 3,4-di-p-toluate Methanesulfonate (salt)
43. .alpha.((tert-butylamino)methyl)-3,4-dihydroxybenzyl Alcohol 3,4-di-p-toluate Methanesulphonate (salt)
44. 4-(2-(tert-butylamino)-1-hydroxyethyl)-1,2-phenylene Bis(4-methylbenzoate) Methanesulfonate (salt)
45. 4-(2-(tert-butylamino)-1-hydroxyethyl)-1,2-phenylene Bis(4-methylbenzoate) Methanesulphonate (salt)
46. 4-(2-(tert-butylamino)-1-hydroxyethyl)-o-phenylene Di-p-toluate Methanesulphonate (salt)
47. 4-methyl-benzoic Acid 1,1'-[4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-1,2-phenylene] Ester Methanesulfonate
48. Alpha ((t-butylamino)methyl)-3,4-dihydroxybenzyl Alcohol 3,4-di(p-toluate) Methanesulfonate
49. Alpha ((t-butylamino)methyl)-3,4-dihydroxybenzyl Alcohol 3,4-di(p-toluate) Methanesulphonate
50. Benzoic Acid, 4-methyl-, 4-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-1,2-phenylene Ester Methanesulphonate (salt)
51. Benzoic Acid, 4-methyl-, 4-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-1,2-phenylene Ester, Methanesulfonate (1:1)
52. Benzoic Acid, 4-methyl-, 4-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-1,2-phenylene Ester, Methanesulphonate (1:1)
| Molecular Weight | 557.7 g/mol |
|---|---|
| Molecular Formula | C29H35NO8S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 10 |
| Exact Mass | 557.20833825 g/mol |
| Monoisotopic Mass | 557.20833825 g/mol |
| Topological Polar Surface Area | 148 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 751 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
ABOUT THIS PAGE
85
PharmaCompass offers a list of Bitolterol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bitolterol manufacturer or Bitolterol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bitolterol manufacturer or Bitolterol supplier.
PharmaCompass also assists you with knowing the Bitolterol API Price utilized in the formulation of products. Bitolterol API Price is not always fixed or binding as the Bitolterol Price is obtained through a variety of data sources. The Bitolterol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bitolterol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bitolterol, including repackagers and relabelers. The FDA regulates Bitolterol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bitolterol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bitolterol supplier is an individual or a company that provides Bitolterol active pharmaceutical ingredient (API) or Bitolterol finished formulations upon request. The Bitolterol suppliers may include Bitolterol API manufacturers, exporters, distributors and traders.
Bitolterol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bitolterol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bitolterol GMP manufacturer or Bitolterol GMP API supplier for your needs.
A Bitolterol CoA (Certificate of Analysis) is a formal document that attests to Bitolterol's compliance with Bitolterol specifications and serves as a tool for batch-level quality control.
Bitolterol CoA mostly includes findings from lab analyses of a specific batch. For each Bitolterol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bitolterol may be tested according to a variety of international standards, such as European Pharmacopoeia (Bitolterol EP), Bitolterol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bitolterol USP).
